142 related articles for article (PubMed ID: 27570220)
1. Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis.
Stuhlmüller B; Mans K; Tandon N; Bonin MO; Smiljanovic B; Sörensen TA; Schendel P; Martus P; Listing J; Detert J; Backhaus M; Neumann T; Winchester RJ; Burmester GR; Häupl T
Clin Immunol; 2016 Oct; 171():50-61. PubMed ID: 27570220
[TBL] [Abstract][Full Text] [Related]
2. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years.
Rau R; Herborn G; Zueger S; Fenner H
J Rheumatol; 2000 Nov; 27(11):2566-75. PubMed ID: 11093435
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate.
Prasad S; Tripathi D; Rai MK; Aggarwal S; Mittal B; Agarwal V
Int J Rheum Dis; 2014 Nov; 17(8):878-86. PubMed ID: 24734954
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor.
Farutin V; Prod'homme T; McConnell K; Washburn N; Halvey P; Etzel CJ; Guess J; Duffner J; Getchell K; Meccariello R; Gutierrez B; Honan C; Zhao G; Cilfone NA; Gunay NS; Hillson JL; DeLuca DS; Saunders KC; Pappas DA; Greenberg JD; Kremer JM; Manning AM; Ling LE; Capila I
Arthritis Res Ther; 2019 Oct; 21(1):216. PubMed ID: 31647025
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
[TBL] [Abstract][Full Text] [Related]
6. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.
Rizzo R; Rubini M; Govoni M; Padovan M; Melchiorri L; Stignani M; Carturan S; Ferretti S; Trotta F; Baricordi OR
Pharmacogenet Genomics; 2006 Sep; 16(9):615-23. PubMed ID: 16906016
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis.
Heldt C; Listing J; Sözeri O; Bläsing F; Frischbutter S; Müller B
Arthritis Rheum; 2003 Oct; 48(10):2779-87. PubMed ID: 14558083
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate--a hospital-based study.
Ali AA; Moatter T; Baig JA; Iqbal A; Hussain A; Iqbal MP
J Pak Med Assoc; 2006 Oct; 56(10):452-6. PubMed ID: 17144392
[TBL] [Abstract][Full Text] [Related]
9. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
Lima A; Bernardes M; Azevedo R; Medeiros R; Seabra V
Int J Mol Sci; 2015 Jun; 16(6):13760-80. PubMed ID: 26086825
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
Kooloos WM; Wessels JA; van der Straaten T; Allaart CF; Huizinga TW; Guchelaar HJ
Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
14. Study of association between HLA-DR4 and DR53 and autoantibody detection in rheumatoid arthritis.
Zhou Y; Tan L; Que Q; Li H; Cai L; Cao L; Ye Q; Xiong J
J Immunoassay Immunochem; 2013; 34(2):126-33. PubMed ID: 23537298
[TBL] [Abstract][Full Text] [Related]
15. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
Keystone EC; Haraoui B; Guérette B; Mozaffarian N; Liu S; Kavanaugh A
J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate pharmacogenetics in rheumatoid arthritis.
Brinker RR; Ranganathan P
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
[TBL] [Abstract][Full Text] [Related]
17. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
18. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
Arthritis Rheum; 2004 Sep; 50(9):2750-6. PubMed ID: 15457442
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
20. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
Haroon N; Srivastava R; Misra R; Aggarwal A
J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
